Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Amit Bar-Or in 2017
The most common conditions of Medicare patients that Amit Bar-Or treated during 2017 were hypertension.
75 | |
(No ratings)
Amit Bar-Or is a null in Philadelphia, PA specializing in psychiatry & neurology. Amit Bar-Or is affiliated with UNIVERSITY OF PENN-MEDICAL GROUP and Penn Neuroscience Center - Neurology.
3400 Civic Center Boulevard
Philadelphia, PA 19104
The most common conditions of Medicare patients that Amit Bar-Or treated during 2017 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Amit Bar-Or treated as a null in Philadelphia, PA during 2018 were hospital care and inpatient care.
Volume of procedures performed by Amit Bar-Or for Medicare patients.
hospital care | 10 |
---|---|
inpatient care | 10 |
Information about Medicare patients treated by Amit Bar-Or.
Male | 19 |
---|---|
Female | 19 |
Non-Hispanic White | 24 |
---|---|
Black | 0 |
Hispanic | 0 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 17 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Amit Bar-Or treated during 2018 were hypertension, high cholesterol, chronic kidney disease and heart failure.
Hypertension | 75 |
---|---|
High Cholesterol | 63 |
Stroke | 0 |
Ischemic Heart Disease | 42 |
Depression | 34 |
Chronic Kidney Disease | 55 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 42 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 34 |
Cancer | 0 |
Information about Medicare patients treated by Amit Bar-Or.
Male | 11 |
---|---|
Female | 15 |
The most common conditions of Medicare patients that Amit Bar-Or treated during 2019 were hypertension and high cholesterol.
Hypertension | 65 |
---|---|
High Cholesterol | 42 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The most common conditions of Medicare patients that Amit Bar-Or treated during 2020 were hypertension.
Hypertension | 55 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Amit Bar-Or treated as a null in Philadelphia, PA during 2021 were and .
Volume of procedures performed by Amit Bar-Or for Medicare patients.
doctor visit | 10 |
---|
Volume of procedures performed by Amit Bar-Or for Medicare patients.
The highest averages for the top procedures that Amit Bar-Or treated as a null in Philadelphia, PA were hospital care and inpatient care.
doctor visit | 10 |
---|---|
hospital care | 10 |
inpatient care | 10 |
Information about Medicare patients treated by Amit Bar-Or.
Female | 3 |
---|---|
Male | 3 |
Black / African American | 0 |
---|---|
Asian / Pacific Islander | 0 |
Non-Hispanic White | 2 |
Native American / Alaskan Native | 0 |
Hispanic | 0 |
Other | 0 |
75 to 84 | 0 |
---|---|
85 and over | 0 |
Less than 65 | 0 |
65 to 74 | 1 |
The highest averages of the most common conditions of Medicare patients that Amit Bar-Or treated were hypertension, high cholesterol, chronic kidney disease and dementia.
Hypertension | 27 |
---|---|
High Cholesterol | 10 |
Stroke | 0 |
Ischemic Heart Disease | 4 |
Depression | 3 |
Chronic Kidney Disease | 5 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 4 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Atrial Fibrillation | 0 |
Dementia | 3 |
Cancer | 0 |
He completed residency at Massachusetts General Hospital. He has a state license in Pennsylvania.
Residency: Massachusetts General Hospital (1997)
Licensed In: Pennsylvania
Amit Bar-Or is associated with these hospitals and organizations:
Amit Bar-Or appears to accept the following insurance providers: Geisinger Health Plan, Clover Health Plan, Provider Partners Health Plan, Keystone First Medicare, HealthAmerica / HealthAssurance, a Coventry Plan, Aetna US Healthcare, NJ Medicaid, PA Medicaid, NJ Qualcare, Homestead Smart Health Plans/Claim Watcher, Veterans Choice Program, Centivo Health Plan, PA Medicare, Rail Road Medicare / Palmetto GBA, UnitedHealthcare Community Plan, Horizon Blue Cross Blue Shield of New Jersey, PA Health and Wellness (Centene) Medicare, Global Medical Management, Tricare, Humana / Choicecare, Gateway Health Plan, Oxford Health Plan, Imagine Health 360, HealthSmart, Independence Blue Cross (Keystone East), United Healthcare, Humana / Medicare, Keystone First, HealthPartners Medicare, Highmark Blue Shield, Devon Health Services (Americare), Cigna HealthSpring, Geisinger Medicaid, HealthPartners, Oscar Health Plan of PA, US Family Health Plan and Cigna.
According to our sources, Amit Bar-Or accepts the following insurance providers:
Amit Bar-Or does not have any reviews yet, be the first to leave a review of Amit Bar-Or here: Leave a Review
(No ratings)
These charts describe general payments received by Amit Bar-Or. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
GENZYME CORPORATION |
$92,267
NO PRODUCT DISCUSSED $29,417 |
LEMTRADA $27,500 |
AUBAGIO $22,831 |
PIPELINE-MS $100 |
$12,419 |
|
---|---|---|---|---|---|---|
Novartis Pharma AG |
$73,016
OMB157G $34,004 |
FTY720D_GILENYA_NEUROSCIENCE $16,039 |
OMB157G_ARZERRA_HEMATOLOGY $8,571 |
FTY720D $3,891 |
KESIMPTA $3,226 |
Other $7,285 |
F. Hoffmann-La Roche AG |
$58,698
OCREVUS $44,231 |
$14,467 |
||||
EMD Serono, Inc. |
$58,354
Evobrutinib $6,550 |
Mavenclad $1,407 |
$50,397 |
|||
SANOFI-AVENTIS U.S. LLC |
$48,637
LEMTRADA $20,849 |
AUBAGIO $18,733 |
NO PRODUCT DISCUSSED $4,584 |
$4,470 |
||
Other |
$195,787
OCREVUS $38,369 |
ZEPOSIA $11,556 |
COPAXONE $6,080 |
MAYZENT $5,937 |
Mavenclad $4,240 |
Other $129,605 |
Consulting Fee | $383,899 |
---|---|
Travel and Lodging | $94,902 |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,138 |
Food and Beverage | $8,723 |
Education | $1,097 |
Amit Bar-Or has received 58 research payments totaling $1,984,182.
Dr. Amit Bar-Or obtained a license to practice in Pennsylvania.